Skip to content

Savara SVRA Total Equity

Total Equity at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$13.01M+137%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$205.8M+402%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$1.34B
Theravance Biopharma logo
Theravance BiopharmaTBPH
$290.59M+75.1%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$562.3M+34.3%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$30.62M+25.2%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+236%
Enterprise value$1.19B+224%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's total equity?
Savara (SVRA) reported total equity of $176.04M in Q1 2026.
How has Savara's total equity changed year-over-year?
Savara's total equity increased by 19.1% year-over-year, from $147.85M to $176.04M.
What is the long-term trend for Savara's total equity?
Over 5 years (2020 to 2025), Savara's total equity has grown at a 25.8% compound annual growth rate (CAGR), from $64.38M to $203.13M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.